1,079 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
BMY Bristol-Myers Squibb Company $61.3 $100.03B Uptrend
Article Searches
Can Pfizer (PFE) Bank on Bavencio for Long-Term Growth? http://www.zacks.com/stock/news/323475/can-pfizer-pfe-bank-on-bavencio-for-long-term-growth?cid=CS-ZC-FT-323475 Sep 18, 2018 - Pfizer's (PFE) latest anti-PD-L1 immunotherapy, Bavencio, is being touted as a significant long-term top-line driver for the company.
‘The New Buffettology’: Finding Durable Competitive Advantages http://www.gurufocus.com/news/740822/the-new-buffettology-finding-durable-competitive-advantages Sep 17, 2018 - ‘The New Buffettology’: Finding Durable Competitive Advantages, Stocks: XTER:PAH3,MCD,YUM,BMY,L,CPB,IPG,ROL,SERV,AXP,WMT, Warren Buffett, release date:Sep 17, 2018
Bristol-Myers Squibb's New Psoriasis Drug Has Echoes of Humira http://www.gurufocus.com/news/740339/bristolmyers-squibbs-new-psoriasis-drug-has-echoes-of-humira Sep 16, 2018 - Bristol-Myers Squibb's New Psoriasis Drug Has Echoes of Humira, Stocks: BMY, release date:Sep 16, 2018
Stocks To Watch: Oracle Looks To Lift Tech Sector https://seekingalpha.com/article/4206464-stocks-watch-oracle-looks-lift-tech-sector?source=feed Sep 15, 2018 - Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Your Daily Pharma Scoop: FibroGen Fast Tracked, Dr. Reddy's Entry, Bristol-Myers Succeeds https://seekingalpha.com/article/4206435-daily-pharma-scoop-fibrogen-fast-tracked-dr-reddys-entry-bristol-myers-succeeds?source=feed_sector_healthcare Sep 15, 2018 - FibroGen's pamrevlumab fast tracked for IPF.Dr. Reddy’s generic launch.Bristol-Myers Squibb succeeds in mid-stage trials.
Your Cancer Highlight: Merck Tightening Its Grips On Front-Line Lung Cancer https://seekingalpha.com/article/4206218-cancer-highlight-merck-tightening-grips-front-line-lung-cancer?source=feed_sector_healthcare Sep 14, 2018 - Merck's application for first-line pembrolizumab in a wider patient population has now been accepted.If approved, it could change the dimension of the market for non-small cell lung cancer.What does t
Pharma Stock Roundup: AZN's Leukemia Drug Wins FDA Nod, MRK's Keytruda in Focus http://www.zacks.com/stock/news/323144/pharma-stock-roundup-azns-leukemia-drug-wins-fda-nod-mrks-keytruda-in-focus?cid=CS-ZC-FT-323144 Sep 14, 2018 - Label expansion of Merck's (MRK) Keytruda and FDA approval of AstraZeneca's (AZN) leukemia drug grab headlines this week
Roche's Child Arthritis Drug's New Formulation Gets FDA Nod http://www.zacks.com/stock/news/323103/roches-child-arthritis-drugs-new-formulation-gets-fda-nod?cid=CS-ZC-FT-323103 Sep 14, 2018 - Roche (RHHBY) gets FDA approval for the subcutaneous formulation of Actemra for the treatment of active systemic juvenile idiopathic arthritis in patients aged two years or older.
Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio Presents at Morgan Stanley 16th Annual Global Healthcare Conference (Transcript) https://seekingalpha.com/article/4206126-bristol-myers-squibb-company-bmy-ceo-giovanni-caforio-presents-morgan-stanley-16th-annual?source=feed_sector_healthcare Sep 13, 2018 - Bristol-Myers Squibb Company (NYSE:BMY) Morgan Stanley 16th Annual Global Healthcare Conference September 13, 2018, 11:10 am ET Executives Giovanni Caforio - Chairman, Chief Executive Officer Analysts
Your Cancer Highlight: Pfizer Gets Ready For An Imminent Lung Cancer Approval https://seekingalpha.com/article/4205856-cancer-highlight-pfizer-gets-ready-imminent-lung-cancer-approval?source=feed_sector_healthcare Sep 12, 2018 - With a PDUFA in lung cancer coming up, Pfizer has a seemingly tall uphill climb to face its competition.There remain possible scenarios where Pfizer's drug could gain and hold relevance in the first-l

Pages: 123456...108

Page 1>

Related Companies

Name Exchange Price Mkt Cap
GSK GlaxoSmithKline PLC NYSE $39.21 $97.25B
AZN Astrazeneca PLC NYSE $37.56 $95.16B
SNY Sanofi NYSE $43.75 $109.14B
LLY Eli Lilly and Company NYSE $105.71 $113.53B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Bristol-Myers Squibb Company